Edit |   |
---|---|
Antigenic Specificity | PDCD1/CD279 (Pidilizumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Pidilizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 antibody in Diffuse Intrinsic Pontine Glioma). |
Immunogen | n/a |
Other Names | Pidilizumab, PDCD1/CD279, 1036730-42-3 |
Gene, Accession # | CAS: 1036730-42-3 |
Catalog # | abx831270 |
Price | please inquire |
Order / More Info | PDCD1/CD279 (Pidilizumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950